1. ALLA AKTIER
  2. NYHETER
  3. LIDDS

LIDDS

Nyheter LIDDS Nyheter alla bolag

LIDDS has decided to write-down intangible assets

MAR

GOTHENBURG, SWEDEN – The board of directors of LIDDS AB (publ) has, taking into account the principle of prudence, decided to write down the book values of all intangible assets in LIDDS AB and Noviga Research AB as of 2024-12-31.

Following the board's decision on April 2, to terminate further development of the project areas Nanodotax, Nanoimod and NOV 202, the board has decided to write down the book values of intangible assets regarding development work and patents. Even though there may be significant values for these assets in the context of sales, the board has decided to take the principle of prudence into account. The write-downs will take place as of year-end 2024/2025, which will result in a deviation for the annual report compared to the published year-end report 2024.

For LIDDS AB, the impairment will amount to SEK 1.4 MSEK and for Noviga Research AB to SEK 1.2 MSEK. After the impairments, the carrying amount of intangible assets amounts to 0 SEK in both companies.

For additional information, please contact

Mats Wiking, CEO and CFO
Phone: +46 (0)70 620 04 00
E-mail: mats.wiking@liddspharma.com

Daniel Lifveredson, Chairman of the Board
Telefon: +46 (0) 70-916 21 01
Email: d.li@excore.com

LIDDS’ Certified Adviser is Redeye AB

LIDDS in brief:

LIDDS is a Swedish pharmaceutical company focused on the development of oncology drugs. LIDDS has a proprietary drug delivery technology, NanoZolid®, on which several projects are based. With NanoZolid, LIDDS can formulate drugs for local/intratumoral administration, with a maintained and controlled release and with minimal negative side-effects. In addition to these projects, LIDDS develops proprietary drug candidate NOV202 that have shown very good results in pre-clinical studies. The company is listed on Nasdaq First North Growth market.

This information is information that LIDDS is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-04-10 13:30 CEST.

Attachments

LIDDS has decided to write-down intangible assets

Datum 2025-04-10, kl 13:30
Källa MFN
Bifogade filer
LIDDS has decided to write-down intangible assets
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!